Cargando…
The conundrum of depression clinical trials: one size does not fit all
In this paper we review the history of antidepressant (AD) development, since the discovery of imipramine in 1957 to the present day. Through this exploration we will show that the increasing placebo response is likely a red herring and that a higher magnitude of placebo response is not an adequate...
Autores principales: | Khan, Arif, Mar, Kaysee Fahl, Brown, Walter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams And Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078483/ https://www.ncbi.nlm.nih.gov/pubmed/29939890 http://dx.doi.org/10.1097/YIC.0000000000000229 |
Ejemplares similares
-
Does the rising placebo response impact antihypertensive clinical trial outcomes? An analysis of data from the Food and Drug Administration 1990-2016
por: Khan, Arif, et al.
Publicado: (2018) -
Decreased suicide rates in recent antidepressant clinical trials
por: Khan, Arif, et al.
Publicado: (2018) -
One (effect) size does not fit at all: Interpreting clinical significance and effect sizes in depression treatment trials
por: Hieronymus, Fredrik, et al.
Publicado: (2020) -
One size does not fit all
por: Tautz, Diethard
Publicado: (2014) -
One-size MAP does not fit all
por: Senussi, Mourad H
Publicado: (2015)